Indications for surgery in MDR-TB
Pulmonary resection should be undertaken in the setting of localised disease, persistent sputum positivity or patient intolerance of medical therapy. It must be emphasised that all types of patients with TB must be first treated medically by pneumologists. Teamwork is of paramount importance in the management of MDR-TB: the better the cooperation between the thoracic surgeon and the chest physician, the better the results of treatment.
Surgery is indicated when pneumologists consider that the patient cannot be cured by medical therapies. It is important to note that at least 3 months of treatment should be given before surgery, if it is feasible at all. The role of the surgeon in this circumstance is to look for indications for surgery and to decide if the patient is a suitable candidate for resectional surgery. Surgery is performed mainly to remove the heavy bacterial burden within the cavity. A destroyed lobe or lung acts in a similar way to cavity disease, and should also be removed when treatment fails.
There are four main indications for surgery, all of which presume that there is adequate cardiopulmonary reserve, as follows: > Failure to convert (failure of anti-TB drug regimen to convert sputum from positive smear to negative smear): positive sputum smear or culture within 2 months before operation, despite at least 4-6 months of treatment with an adequate drug regimen; presence of destroyed lobe or lung (with cavitation, bronchiectasis and bronchostenosis) is associated with high risk of treatment failure or relapse. > Previous relapse(s): previous TB history of two or more relapses and/or one or more relapses during MDR-TB treatment course; if relapse did occur, it may be difficult to re-establish sputum culture conversion. > High profile of drug resistance: infection with strains of M. tuberculosis resistant to four or more drugs. > High or potential risk of relapse: patients not falling into any of the previous categories, but considered likely to relapse despite conversion, as gauged by the presence of a destroyed lung or a lobe. When the probability of negative bacteriological conversion of sputum seems high (i.e. less destroyed lung, initial resistance to isoniazid (INH) and rifampicin (RFP), only resistant to INH and RFP), chemotherapy should be continued for an additional 2-3 months. Should any significant improvement occur clinically then chemotherapy should continue; while "no change" or worsening in clinical, radiological or bacteriological findings indicates surgery.
Surgical resection of lung disease

Pre-operative period
The decision to perform surgery and the extent of surgery, i.e.lobectomy or pneumonectomy, should be made after anatomical localisation of the disease by computed tomography (CT) scan. Perfusion scans are useful in establishing how much functioning lung is likely to be removed. Bronchoscopy is necessary to rule out endobronchial TB, which is quite a rare but important condition that increases post-operative complication rates. Basic spirometry (i.e. forced expiratory volume in one second and forced vital capacity) is adequate for assessing lung function in the majority of patients. Electrocardiography is useful for excluding pulmonary hypertension, which would contraindicate surgery.
In a patient who has not undergone sputum culture conversion, surgery should only be performed when there is no further possibility of an adequate chemotherapeutic regimen. Positive sputum for M. tuberculosis and surgery is not a desirable association. However, sputum negativity by drugs cannot always be achieved; surgery remains the only tool to achieve this goal (to convert sputum from positive culture to negative culture).
Most, if not all, of the patients considered for surgery are in poor physical condition. Serum albumin levels are generally low and must be increased during the pre-operative period. As blood loss from the adhesions between the lung and the chest wall, pericardium and diaphragm is not unusual during separation of the lung, at least four units of blood must be prepared before the operation.
Surgery
During surgery, a double-lumen endotracheal tube is used to isolate the lungs. Prophylaxis with parenteral antibiotics must be started just prior to the incision. Posterolateral thoracotomy is per- 
REVIEW Postgraduate Course ERS Glasgow 2004
bronchopleural fistula (BPF) complication. Lobar resection is the goal of surgery. Pneumonectomy, especially right pneumonectomy, should be avoided whenever possible. There is only limited opportunity for segmental/limited resection.
Generally, the disease will be located in one lobe, with some nodular disease in another lobe or lobes. Nodules in the lungs also contain bacilli, but not as much as in a cavity or a destroyed lobe. Any attempt to remove all the nodules by resecting the entire lobe or by limited resection only causes increased post-operative difficulties and is unnecessary.
If the disease does not invade the entire lung, it locates predominately in the right upper lobe. In patients with MDR-TB, destruction of the left lung requiring pneumonectomy occurs more frequently than in the right lung. Although right-sided total lung destruction is rare, the removal of only the right upper lobe is not always possible because of invasion into the superior segment of the lower lobe with TB. Frequently, there is no plane between the upper lobe and superior segment of the lower lobe. The only way to remove the upper lobe is to separate the lobes by sharp dissection using electrocautery. Linear stapling devices are not generally useful because of thickened parenchyma in association with the disease. In this situation, the surgeon must decide whether to: 1) remove only the upper lobe and leave the lower lobe (that cannot be expanded) open to complication (i.e. prolonged air leak, empyema); or 2) remove all three lobes.
Pre-operative perfusion scan is one tool that can help with the decision. However, the intraoperative finding of an experienced surgeon is the most important consideration in this situation. The possibility of complications if the partially diseased lower lobe is left unresected (because of nodular disease and/or parenchymal air leakage from the separated superior segment of the lower lobe) must be well above the complication rate of a right pneumonectomy if the entire right lung is to be resected. If the probability of post-operative complications does not outweigh the complications of right pneumonectomy, then only the upper lobe should be resected.
Although pneumonectomy is not a desirable resection, complete lung destruction mandates total removal of the lung. Preservation of the bronchial stump by very careful dissection and by buttressing with adjacent structures may decrease the BPF. If the risk of infection in the postpneumonectomy cavity is high, irrigation of the cavity with saline, which maintains mechanical cleaning, might be helpful in addition to parenteral antibiotics.
The resected specimen should be sent for histology, culture and susceptibility. The patient should then be redirected to the related pneumology unit to arrange drug regimen and follow-up. Even when the entire diseased lung is resected, anti-TB treatment should continue for 18-24 months after surgery.
Post-operative period: complications
The most important complication of surgery for TB is BPF. This is more common after right pneumonectomy when compared with all other resections. BPF rate is closely related to positive sputum before surgery, lower albumin level and presence of pre-operative empyema. BPF occurring after TB surgery cannot be managed in the same way as in patients who undergo pneumonectomy for lung cancer. Although muscle flap appears to be a good method to close the stump, patients are generally weak and only have thin muscles. Transsternal-transpericardial closure of the stump must be very carefully used, since the infection can be disseminated to the vital organs in the mediastinum. Re-closure of the stump by thoracotomy in such a diseased bronchus is very hard to achieve. It is our opinion that thoracostoma (open-window thoracostomy) or thoracoplasty is the best way to save the lives in BPF patients with MDR-TB. Other complications of surgery include bleeding, atelectasis, prolonged air leak, empyema, post-pneumonectomy pulmonary oedema and Horner's syndrome. 
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MDR-TB
Continue chemotherapy for 2-6 months with 5-6 drugs (ofwhich at least 1 of them is a parenteral amioglycoside and 1 is oflaxacine) based on previous chemotherapy history and drug susceptibility 
Conclusion
Surgery remains an important adjunctive tool in the management of patients with MDR-TB. The success of surgery in MDR-TB depends on the following criteria: > cooperation and teamwork (chest physicians and thoracic surgeons); > patient compliance to complete the drug regimen, which lasts 18-24 months postoperatively; > familiarity of surgeon with the surgery for TB disease; > adherence to pre-operative and post-operative precautions; > careful follow-up by chest physicians. For answers go to www.breathe-cme.org
Suggested further reading
The correct answers are: 1-b 2-a 3-c 4-c 5-a 6-a 7-d
